Johnson & Johnson (JNJ)
USD 144.75
(-1.13%)
USD 144.75
(-1.13%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 23.4 Billion USD | 7.08% |
| 2022 | 23.19 Billion USD | 13.3% |
| 2021 | 20.47 Billion USD | 20.8% |
| 2020 | 16.94 Billion USD | 12.09% |
| 2019 | 15.11 Billion USD | -3.24% |
| 2018 | 15.62 Billion USD | 10.04% |
| 2017 | 14.19 Billion USD | -20.82% |
| 2016 | 17.93 Billion USD | 17.38% |
| 2015 | 15.27 Billion USD | -12.31% |
| 2014 | 17.42 Billion USD | 12.88% |
| 2013 | 15.43 Billion USD | 6.22% |
| 2012 | 14.52 Billion USD | -10.9% |
| 2011 | 16.3 Billion USD | 20.01% |
| 2010 | 13.58 Billion USD | -4.68% |
| 2009 | 14.25 Billion USD | -4.43% |
| 2008 | 14.91 Billion USD | -13.78% |
| 2007 | 17.29 Billion USD | 27.23% |
| 2006 | 13.59 Billion USD | 0.58% |
| 2005 | 13.51 Billion USD | 4.83% |
| 2004 | 12.89 Billion USD | 13.08% |
| 2003 | 11.4 Billion USD | 12.23% |
| 2002 | 10.16 Billion USD | 24.29% |
| 2001 | 8.17 Billion USD | 24.52% |
| 2000 | 6.56 Billion USD | 6.78% |
| 1999 | 6.14 Billion USD | 7.65% |
| 1998 | 5.71 Billion USD | 25.57% |
| 1997 | 4.54 Billion USD | 2.25% |
| 1996 | 4.44 Billion USD | 24.87% |
| 1995 | 3.56 Billion USD | 24.94% |
| 1994 | 2.85 Billion USD | 23.21% |
| 1993 | 2.31 Billion USD | 4.09% |
| 1992 | 2.22 Billion USD | 2.87% |
| 1991 | 2.16 Billion USD | 0.05% |
| 1990 | 2.16 Billion USD | 29.57% |
| 1989 | 1.66 Billion USD | 27.45% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 5.26 Billion USD | -64.08% |
| 2024 Q1 | 6.83 Billion USD | 34.22% |
| 2024 Q2 | 7.49 Billion USD | 9.75% |
| 2023 Q4 | 5.09 Billion USD | -23.71% |
| 2023 Q2 | 6.76 Billion USD | 7.36% |
| 2023 Q3 | 6.67 Billion USD | -1.4% |
| 2023 Q1 | 6.3 Billion USD | 259.82% |
| 2023 FY | 24.83 Billion USD | 7.08% |
| 2022 Q2 | 6.76 Billion USD | 4.98% |
| 2022 Q3 | 5.88 Billion USD | -12.94% |
| 2022 Q4 | 1.75 Billion USD | -70.24% |
| 2022 FY | 23.19 Billion USD | 13.3% |
| 2022 Q1 | 6.44 Billion USD | 75.1% |
| 2021 Q1 | 7.04 Billion USD | 747.77% |
| 2021 FY | 20.47 Billion USD | 20.8% |
| 2021 Q4 | 3.67 Billion USD | -46.13% |
| 2021 Q3 | 6.82 Billion USD | 4.13% |
| 2021 Q2 | 6.55 Billion USD | -6.91% |
| 2020 Q2 | 4.05 Billion USD | -38.53% |
| 2020 Q3 | 6.15 Billion USD | 51.8% |
| 2020 FY | 16.94 Billion USD | 12.09% |
| 2020 Q1 | 6.59 Billion USD | 49.58% |
| 2020 Q4 | 831 Million USD | -86.49% |
| 2019 FY | 15.11 Billion USD | -3.24% |
| 2019 Q4 | 4.4 Billion USD | -26.11% |
| 2019 Q1 | 5.45 Billion USD | 58.61% |
| 2019 Q2 | 7.48 Billion USD | 37.27% |
| 2019 Q3 | 5.96 Billion USD | -20.28% |
| 2018 Q2 | 5.28 Billion USD | -8.63% |
| 2018 FY | 15.62 Billion USD | 10.04% |
| 2018 Q4 | 3.43 Billion USD | -41.56% |
| 2018 Q3 | 5.88 Billion USD | 11.3% |
| 2018 Q1 | 5.78 Billion USD | 70.76% |
| 2017 Q3 | 5.08 Billion USD | 2.05% |
| 2017 Q4 | 3.38 Billion USD | -33.45% |
| 2017 FY | 14.19 Billion USD | -20.82% |
| 2017 Q1 | 5.86 Billion USD | 24.69% |
| 2017 Q2 | 4.98 Billion USD | -14.97% |
| 2016 FY | 17.93 Billion USD | 17.38% |
| 2016 Q2 | 5.23 Billion USD | -6.05% |
| 2016 Q1 | 5.57 Billion USD | 20.1% |
| 2016 Q3 | 5.53 Billion USD | 5.69% |
| 2016 Q4 | 4.7 Billion USD | -15.03% |
| 2015 Q1 | 5.71 Billion USD | 90.56% |
| 2015 Q3 | 4.25 Billion USD | -27.54% |
| 2015 FY | 15.27 Billion USD | -12.31% |
| 2015 Q4 | 4.64 Billion USD | 9.07% |
| 2015 Q2 | 5.87 Billion USD | 2.78% |
| 2014 Q2 | 5.75 Billion USD | 3.23% |
| 2014 Q4 | 2.99 Billion USD | -56.8% |
| 2014 Q3 | 6.94 Billion USD | 20.53% |
| 2014 Q1 | 5.57 Billion USD | 73.12% |
| 2014 FY | 17.42 Billion USD | 12.88% |
| 2013 Q3 | 3.95 Billion USD | -19.57% |
| 2013 Q1 | 4.45 Billion USD | 127.62% |
| 2013 FY | 15.43 Billion USD | 6.22% |
| 2013 Q4 | 3.22 Billion USD | -18.43% |
| 2013 Q2 | 4.91 Billion USD | 10.36% |
| 2012 FY | 14.52 Billion USD | -10.9% |
| 2012 Q4 | 1.95 Billion USD | -55.66% |
| 2012 Q3 | 4.4 Billion USD | 69.12% |
| 2012 Q1 | 5.19 Billion USD | 55.5% |
| 2012 Q2 | 2.6 Billion USD | -49.79% |
| 2011 FY | 16.3 Billion USD | 20.01% |
| 2011 Q4 | 3.33 Billion USD | -15.19% |
| 2011 Q3 | 3.93 Billion USD | -9.41% |
| 2011 Q2 | 4.34 Billion USD | -5.97% |
| 2011 Q1 | 4.62 Billion USD | 33.35% |
| 2010 Q3 | 4.03 Billion USD | -7.01% |
| 2010 FY | 13.58 Billion USD | -4.68% |
| 2010 Q1 | 4.79 Billion USD | 55.7% |
| 2010 Q2 | 4.33 Billion USD | -9.49% |
| 2010 Q4 | 3.46 Billion USD | -14.1% |
| 2009 Q3 | 4.29 Billion USD | -2.01% |
| 2009 Q4 | 3.07 Billion USD | -28.25% |
| 2009 Q2 | 4.37 Billion USD | -6.31% |
| 2009 Q1 | 4.67 Billion USD | 25.14% |
| 2009 FY | 14.25 Billion USD | -4.43% |
| 2008 Q1 | 4.82 Billion USD | 19.16% |
| 2008 FY | 14.91 Billion USD | -13.78% |
| 2008 Q4 | 3.73 Billion USD | -10.82% |
| 2008 Q3 | 4.18 Billion USD | -3.61% |
| 2008 Q2 | 4.34 Billion USD | -9.99% |
| 2007 Q2 | 3.76 Billion USD | -21.27% |
| 2007 Q1 | 4.77 Billion USD | 42.47% |
| 2007 FY | 17.29 Billion USD | 27.23% |
| 2007 Q4 | 4.05 Billion USD | -13.99% |
| 2007 Q3 | 4.71 Billion USD | 25.23% |
| 2006 Q4 | 3.35 Billion USD | -11.46% |
| 2006 FY | 13.59 Billion USD | 0.58% |
| 2006 Q1 | 3.07 Billion USD | 26.58% |
| 2006 Q2 | 3.38 Billion USD | 10.19% |
| 2006 Q3 | 3.78 Billion USD | 11.88% |
| 2005 Q2 | 3.7 Billion USD | -2.37% |
| 2005 Q4 | 2.42 Billion USD | -23.99% |
| 2005 Q3 | 3.19 Billion USD | -13.75% |
| 2005 Q1 | 3.79 Billion USD | 39.67% |
| 2005 FY | 13.51 Billion USD | 4.83% |
| 2004 Q3 | 3.37 Billion USD | -0.97% |
| 2004 Q2 | 3.4 Billion USD | 0.06% |
| 2004 Q4 | 2.71 Billion USD | -19.51% |
| 2004 FY | 12.89 Billion USD | 13.08% |
| 2004 Q1 | 3.4 Billion USD | 68.43% |
| 2003 Q3 | 2.77 Billion USD | -25.15% |
| 2003 Q1 | 2.89 Billion USD | 31.95% |
| 2003 Q4 | 2.02 Billion USD | -27.28% |
| 2003 FY | 11.4 Billion USD | 12.23% |
| 2003 Q2 | 3.71 Billion USD | 28.43% |
| 2002 Q4 | 2.19 Billion USD | -16.98% |
| 2002 FY | 10.16 Billion USD | 24.29% |
| 2002 Q3 | 2.63 Billion USD | -1.75% |
| 2002 Q2 | 2.68 Billion USD | 1.55% |
| 2002 Q1 | 2.64 Billion USD | 56.51% |
| 2001 FY | 8.17 Billion USD | 24.52% |
| 2001 Q4 | 1.69 Billion USD | -18.71% |
| 2001 Q3 | 2.07 Billion USD | -9.33% |
| 2001 Q2 | 2.29 Billion USD | 8.52% |
| 2001 Q1 | 2.11 Billion USD | 67.7% |
| 2000 Q1 | 1.8 Billion USD | 55.83% |
| 2000 Q2 | 1.85 Billion USD | 2.94% |
| 2000 Q3 | 1.72 Billion USD | -6.95% |
| 2000 Q4 | 1.26 Billion USD | -27.04% |
| 2000 FY | 6.56 Billion USD | 6.78% |
| 1999 Q4 | 1.15 Billion USD | -28.31% |
| 1999 FY | 6.14 Billion USD | 7.65% |
| 1999 Q1 | 1.72 Billion USD | -4.69% |
| 1999 Q2 | 1.69 Billion USD | -1.68% |
| 1999 Q3 | 1.61 Billion USD | -5.0% |
| 1998 FY | 5.71 Billion USD | 25.57% |
| 1998 Q1 | 1.36 Billion USD | 55.66% |
| 1998 Q4 | 1.81 Billion USD | 43.32% |
| 1998 Q3 | 1.26 Billion USD | -0.47% |
| 1998 Q2 | 1.27 Billion USD | -6.68% |
| 1997 Q2 | 1.24 Billion USD | -5.61% |
| 1997 Q4 | 875 Million USD | -21.1% |
| 1997 Q3 | 1.1 Billion USD | -10.92% |
| 1997 Q1 | 1.31 Billion USD | 63.44% |
| 1997 FY | 4.54 Billion USD | 2.25% |
| 1996 FY | 4.44 Billion USD | 24.87% |
| 1996 Q1 | 1.22 Billion USD | 40.41% |
| 1996 Q4 | 807 Million USD | -33.69% |
| 1996 Q3 | 1.21 Billion USD | 1.33% |
| 1996 Q2 | 1.2 Billion USD | -1.8% |
| 1995 FY | 3.56 Billion USD | 24.94% |
| 1995 Q4 | 871 Million USD | 1.52% |
| 1995 Q3 | 858 Million USD | -10.34% |
| 1995 Q1 | 1 Billion USD | 63.52% |
| 1995 Q2 | 957 Million USD | -4.68% |
| 1994 Q2 | 730 Million USD | 1.67% |
| 1994 Q3 | 791 Million USD | 8.36% |
| 1994 FY | 2.85 Billion USD | 23.21% |
| 1994 Q4 | 614 Million USD | -22.38% |
| 1994 Q1 | 718 Million USD | 57.11% |
| 1993 FY | 2.31 Billion USD | 4.09% |
| 1993 Q4 | 457 Million USD | -21.07% |
| 1993 Q3 | 579 Million USD | -10.51% |
| 1993 Q1 | 629 Million USD | 40.09% |
| 1993 Q2 | 647 Million USD | 2.86% |
| 1992 Q4 | 449 Million USD | -20.11% |
| 1992 FY | 2.22 Billion USD | 2.87% |
| 1992 Q3 | 562 Million USD | -10.94% |
| 1992 Q1 | 581 Million USD | 24.68% |
| 1992 Q2 | 631 Million USD | 8.61% |
| 1991 Q2 | 597 Million USD | -0.17% |
| 1991 FY | 2.16 Billion USD | 0.05% |
| 1991 Q1 | 598 Million USD | 1.53% |
| 1991 Q4 | 466 Million USD | -6.8% |
| 1991 Q3 | 500 Million USD | -16.25% |
| 1990 FY | 2.16 Billion USD | 29.57% |
| 1990 Q3 | 415 Million USD | -37.03% |
| 1990 Q1 | 655 Million USD | 73.74% |
| 1990 Q4 | 589 Million USD | 41.93% |
| 1990 Q2 | 659 Million USD | 0.61% |
| 1989 Q4 | 377 Million USD | -15.85% |
| 1989 FY | 1.66 Billion USD | 27.45% |
| 1989 Q2 | 2.39 Billion USD | 444.42% |
| 1989 Q1 | 439 Million USD | 108.14% |
| 1989 Q3 | 448 Million USD | -81.26% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbbVie Inc. | 12.75 Billion USD | -83.499% |
| Bristol-Myers Squibb Company | 16.59 Billion USD | -41.035% |
| Bristol-Myers Squibb Company Ce | 16.59 Billion USD | -41.035% |
| Eli Lilly and Company | 10.32 Billion USD | -126.713% |
| Merck & Co., Inc. | 2.95 Billion USD | -692.451% |
| Novartis AG | 9.76 Billion USD | -139.625% |
| Organon & Co. | 1.32 Billion USD | -1661.4% |
| Pfizer Inc. | 3.35 Billion USD | -596.904% |